查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
中空纤维过滤的市场规模，占有率，趋势分析:各材料，各技术，各用途，各终端用户，各地区展望，竞争策略，至2030年的各市场区隔预测
市场调查报告书
商品编码
1070365

中空纤维过滤的市场规模，占有率，趋势分析:各材料，各技术，各用途，各终端用户，各地区展望，竞争策略，至2030年的各市场区隔预测

Hollow Fiber Filtration Market Size, Share & Trends Analysis By Material, By Technique, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 213 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球中空纤维过滤的市场规模，预计今后以11.2％的年复合成长率扩大，至2030年达到7亿9,670万美元。感染疾病的流行和对健康的意识高涨，影响对疫苗和单株抗体，个人化医疗的细胞培养的引进。

本报告提供全球中空纤维过滤市场相关调查，市场概要，以及各材料，各技术，各用途，各终端用户，各地区的趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 市场动态

  • 成长要素，阻碍因素，机会，课题的分析
    • 促进因素
    • 阻碍因素
    • 市场机会
    • 课题
  • COVID-19中空纤维过滤市场的影响

第5章 市场变数及预测

  • SWOT分析
    • 优势
    • 弱点
    • 机会
    • 威胁
  • PESTEL分析
    • 政治形势
    • 经济形势
    • 社会形势
    • 技术形势
    • 环境形势
    • 法律上的形势
  • 波特的五力分析
    • 卖主谈判力
    • 买方议价能力
    • 替代威胁
    • 新加入厂商的威胁
    • 竞争企业间的敌对关係
  • 热图分析

第6章 中空纤维过滤市场，各材料，2019年～2030年(100万美元)

  • 陶瓷
  • 其他的高分子材料
  • 高分子
  • 聚二氟亚乙烯(PVDF)
  • PS/PES

第7章 中空纤维过滤市场，各技术，2019年～2030年(100万美元)

  • 微过滤
    • 不满0.2微米
    • 0.2～0.7微米
  • 超过滤
    • 50,000 kDa以上
    • 10,000kDa～50,000kDa
    • 不满10,000 kDa

第8章 中空纤维过滤市场，各用途，2019年～2030年(100万美元)

  • 连续细胞灌流
  • 收穫和清澄化
  • 浓缩和血液透析机过滤

第9章 中空纤维过滤市场，各终端用户，2019年～2030年(100万美元)

  • 製药公司，生物科技厂商
  • CRO，CMO
  • 其他

第10章 中空纤维过滤市场，各地区，2019年～2030年(100万美元)

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 中东、非洲
    • 沙乌地阿拉伯王国
    • 阿拉伯联合大公国
    • 其他

第11章 企业简介

  • Alpha Plan GmbH
  • Antylia Scientific
  • APAH technologies
  • Asahi Kasei Corporation
  • Biotree
  • BiOZEEN Pvt. Ltd.
  • Cantel Medical
  • CoorsTek, Inc.
  • Danaher
  • Koch Industries Inc.
  • Kuraray Co., Ltd.
  • MANN+HUMMEL Holding GmbH
  • Meissner Filtration Product, Inc
  • Parker-Hannifin Corp
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • TOYOBO CO., LTD
简介目录
Product Code: BIOT2215

Global Hollow Fiber Filtration Market projected to be worth USD 796.7 million by 2030.

According to SPER Market Research, the Hollow Fiber Filtration Market estimated to reach USD 796.7 million by 2030 with a CAGR of 11.2%. Growing exploit of single use technologies, increasing biopharmaceutical industries, rising inclination towards continuous manufacturing; are the key factors which act as the fuel for the escalation of the market.

Impact of COVID-19 on the Hollow Fiber Filtration Market

The outbreak of COVID-19 has boosted the research for the treatment and vaccine manufacture, with the hollow fiber filtration by the pharmaceutical, biopharmaceutical companies, and the players of the Hollow fiber filtration market to target the corona virus infection. Thus COVID-19 has a positive impact on this market.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030

Segments covered By Material, By Technique, By Application, By End-Users, By Region

  • Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa
  • Companies Covered: Alpha Plan GmbH, Alpha Plan GmbH, Antylia Scientific, APAH technologies, Asahi Kasei Corporation, Biotree, BiOZEEN Pvt. Ltd., Cantel Medical, CoorsTek, Inc., Danaher, Koch Industries Inc., Kuraray Co., Ltd., MANN+HUMMEL Holding GmbH, Meissner Filtration Product, Inc, MMS Membrane System, Parker-Hannifin Corp, Repligen Corporation, Sartorius Stedim Biotech S.A, TOYOBO CO., LTD.

Driver: expansion in the biopharmaceutical industry

Growing usage of single-use technologies, increase in the biopharmaceutical industry, growing preference for continuous manufacturing; are the key factors for the expansion of the market.

Opportunity: Emerging economies

In Emerging economies, there is rising government support and private investments, demand for single used technology, increasing biosimilars, increasing investments in cell-based research, this growth in biopharmaceuticals is going to offer enormous opportunities for the players in the Hollow Fiber Filtration Market.

Challenges: Membrane fouling and fiber breakage

The main problems regarding hollow fiber filtration are; permanent fouling and fiber breakage, moderate capital costs, high operating costs. These are the challenges to the market.

Hollow Fiber Filtration Market, By Material:

Based on the Material, Hollow Fiber Filtration Market is segmented as; Ceramic, Polymeric, Polyvinylidene fluoride (PVDF), PS/PES, Other polymeric materials.

Hollow Fiber Filtration Market, By Technique:

Based on the Technique, Hollow Fiber Filtration Market is segmented as; Microfiltration (<0.2 Micron Meter, >0.2 Micron Meter and <0.7 Micron Meter), Ultrafiltration (>50,000 kDa, >10,000 kDa and <50,000 kDa, <10,000 kDa).

Hollow Fiber Filtration Market, By Application:

Based on the Application, Hollow Fiber Filtration Market is segmented as; Continuous Cell Perfusion, Harvest and Clarification, Concentration and Diafiltration.

Hollow Fiber Filtration Market, By End User:

Based on the End-Users, Hollow Fiber Filtration Market is segmented as; Pharmaceutical and Biotechnology Manufacturers, Contract Research Organization and Contract Manufacturing Organization (CROs & CMOs), other end users.

Hollow Fiber Filtration Market, By Region:

North America owns the prime share of this market; this is due to the focus of companies on new products such as perfusion systems, ease, and cost-efficiency of hollow fiber filters and the growing demand for filtration systems for the biopharmaceuticals industry.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Hollow Fiber Filtration Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Hollow Fiber Filtration Market, By Material, 2019-2030 (USD Million)

  • 6.1. Ceramic
  • 6.2. Other polymeric materials
  • 6.3. Polymeric
  • 6.4. Polyvinylidene fluoride (PVDF)
  • 6.5. PS/PES

7. Hollow Fiber Filtration Market, By Technique, 2019-2030 (USD Million)

  • 7.1. Microfiltration
    • 7.1.1. <0.2 Micron Meter
    • 7.1.2. >0.2 Micron Meter and <0.7 Micron Meter
  • 7.2. Ultrafiltration
    • 7.2.1. >50,000 kDa
    • 7.2.2. >10,000 kDa and <50,000 kDa
    • 7.2.3. <10,000 kDa

8. Hollow Fiber Filtration Market, By Application, 2019-2030 (USD Million)

  • 8.1. Continuous Cell Perfusion
  • 8.2. Harvest and Clarification
  • 8.3. Concentration and Diafiltration

9. Hollow Fiber Filtration Market, By End User, 2019-2030 (USD Million)

  • 9.1. Pharmaceutical and Biotechnology Manufacturers
  • 9.2. Contract Research Organization and Contract Manufacturing Organization (CROs & CMOs)
  • 9.3. Other end users

10. Hollow Fiber Filtration Market, By Region, 2019-2030 (USD Million)

  • 10.1. North America
    • 10.1.1. United States
    • 10.1.2. Canada
    • 10.1.3. Mexico
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. United Kingdom
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. South Korea
    • 10.3.6. Rest of Asia-Pacific
  • 10.4. South America
    • 10.4.1. Brazil
    • 10.4.2. Argentina
    • 10.4.3. Rest of South America
  • 10.5. Middle East & Africa
    • 10.5.1. Kingdom of Saudi Arabia
    • 10.5.2. United Arab Emirates
    • 10.5.3. Rest of Middle East & Africa

11. Company Profiles

  • 11.1. Alpha Plan GmbH
    • 11.1.1. Company details
    • 11.1.2. Financial outlook
    • 11.1.3. Product summary
    • 11.1.4. Recent developments
  • 11.2. Antylia Scientific
    • 11.2.1. Company details
    • 11.2.2. Financial outlook
    • 11.2.3. Product summary
    • 11.2.4. Recent developments
  • 11.3. APAH technologies
    • 11.3.1. Company details
    • 11.3.2. Financial outlook
    • 11.3.3. Product summary
    • 11.3.4. Recent developments
  • 11.4. Asahi Kasei Corporation
    • 11.4.1. Company details
    • 11.4.2. Financial outlook
    • 11.4.3. Product summary
    • 11.4.4. Recent developments
  • 11.5. Biotree
    • 11.5.1. Company details
    • 11.5.2. Financial outlook
    • 11.5.3. Product summary
    • 11.5.4. Recent developments
  • 11.6. BiOZEEN Pvt. Ltd.
    • 11.6.1. Company details
    • 11.6.2. Financial outlook
    • 11.6.3. Product summary
    • 11.6.4. Recent developments
  • 11.7. Cantel Medical
    • 11.7.1. Company details
    • 11.7.2. Financial outlook
    • 11.7.3. Product summary
    • 11.7.4. Recent developments
  • 11.8. CoorsTek, Inc.
    • 11.8.1. Company details
    • 11.8.2. Financial outlook
    • 11.8.3. Product summary
    • 11.8.4. Recent developments
  • 11.9. Danaher
    • 11.9.1. Company details
    • 11.9.2. Financial outlook
    • 11.9.3. Product summary
    • 11.9.4. Recent developments
  • 11.10. Koch Industries Inc.
    • 11.10.1. Company details
    • 11.10.2. Financial outlook
    • 11.10.3. Product summary
    • 11.10.4. Recent developments
  • 11.11. Kuraray Co., Ltd.
    • 11.11.1. Company details
    • 11.11.2. Financial outlook
    • 11.11.3. Product summary
    • 11.11.4. Recent developments
  • 11.12. MANN+HUMMEL Holding GmbH
    • 11.12.1. Company details
    • 11.12.2. Financial outlook
    • 11.12.3. Product summary
    • 11.12.4. Recent developments
  • 11.13. Meissner Filtration Product, Inc
    • 11.13.1. Company details
    • 11.13.2. Financial outlook
    • 11.13.3. Product summary
    • 11.13.4. Recent developments
  • 11.14. Parker-Hannifin Corp
    • 11.14.1. Company details
    • 11.14.2. Financial outlook
    • 11.14.3. Product summary
    • 11.14.4. Recent developments
  • 11.15. Repligen Corporation
    • 11.15.1. Company details
    • 11.15.2. Financial outlook
    • 11.15.3. Product summary
    • 11.15.4. Recent developments
  • 11.16. Sartorius Stedim Biotech S.A
    • 11.16.1. Company details
    • 11.16.2. Financial outlook
    • 11.16.3. Product summary
    • 11.16.4. Recent developments
  • 11.17. TOYOBO CO., LTD
    • 11.17.1 Company details
    • 11.17.2 Financial outlook
    • 11.17.3 Product summary
    • 11.17.4 Recent developments